New Organ-Specific Pharmacological Strategies Interfering With Signaling Pathways In Inflammatory Disorders/Autoimmune Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|6|2|279-291

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.2, 2011-05, pp. : 279-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 260-266

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Towards Tailored Treatment - New Organ-Specific Drug Strategies Interfering in Signal Transduction (Guest Editors: Jai Prakash and Martin H. de Borst)]

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 234-236

Bentham Science Publishers

Access to resources Recommend Favorite

Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease

By Bardella Maria Teresa   Elli Luca   Matteis Sara   Floriani Irene   Torri Valter   Piodi Luca  

Annals of Medicine, Vol. 41, Iss. 2, 2009-01 ,pp. : 139-143

Informa Healthcare

Access to resources Recommend Favorite

Intracellular signaling pathways pave roads to recovery for mood disorders

By Tanis Keith   Duman Ronald  

Annals of Medicine, Vol. 39, Iss. 7, 2007-01 ,pp. : 531-544

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological Strategies Against Glucocorticoid-mediated Brain Damage During Chronic Disorders

By  

Recent Patents on CNS Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 196-204

Bentham Science Publishers

Access to resources Recommend Favorite